| Typicality: | 0.322 |
| Saliency: | 0.169 |
| for hepatitis b | 3 | other |
| compound → be in → clinical development | 4 |
| compound → be developed for → clinical trials | 3 |
| negative | neutral | positive |
| 0.124 | 0.732 | 0.144 |
| Raw frequency | 7 |
| Normalized frequency | 0.169 |
| Modifier score | 0.500 |
| Perplexity | 246.759 |